Literature DB >> 8380464

The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence.

I Mikaélian1, E Drouet, V Marechal, G Denoyel, J C Nicolas, A Sergeant.   

Abstract

The Epstein-Barr virus BZLF1 gene product EB1 (also called ZEBRA and Zta), is a transcription factor belonging to the bZIP (basic domain leucine zipper) family of nuclear proteins. Translocation to the nucleus of EB1 (J. Becker, U. Leser, M. Marschall, A. Langford, W. Jilg, H. Gelderblom, P. Reichart, and H. Wolf, Proc. Natl. Acad. Sci. USA 88:8332-8336, 1991) and of two other bZIP proteins, c-Jun and c-Fos (P. Roux, J.-M. Blanchard, A. Fernandez, N. Lamb, P. Jeanteur, and M. Piechaczyk, Cell 63:341-351, 1990), has been shown to be subject to regulation. We show here that for both EB1 and Jun the nuclear targeting signals (NTS) in the proteins' primary sequences are two clusters of positively charged amino acids. These clusters, called BRA and BRB, are necessary and sufficient to direct beta-galactosidase to the nuclear compartment and act as a bipartite NTS. They are conserved among all the bZIP proteins, and although they are not identical, they probably share the same function. Site-directed mutagenesis studies made on these basic clusters suggest that they also act as a bipartite NTS in the EB1 protein. Our results also demonstrate that in EB1 and Jun, these bipartite NTS are superimposed with bipartite DNA-binding domains, since BRA and BRB are required in vitro for direct and specific contact between these proteins and their DNA-binding sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380464      PMCID: PMC237425     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  A general and fast method to generate multiple site directed mutations.

Authors:  I Mikaelian; A Sergeant
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

2.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

4.  Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells.

Authors:  W J King; G L Greene
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

5.  Nuclear localization of unoccupied oestrogen receptors.

Authors:  W V Welshons; M E Lieberman; J Gorski
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

6.  A short amino acid sequence able to specify nuclear location.

Authors:  D Kalderon; B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

7.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.

Authors:  B Sugden; K Marsh; J Yates
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

9.  Negative regulatory sequences in the EIa-inducible enhancer of the adenovirus-2 early EIIa promoter.

Authors:  P Jalinot; C Kédinger
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

10.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  22 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

3.  Differential gene regulation by selective association of transcriptional coactivators and bZIP DNA-binding domains.

Authors:  Benoit Miotto; Kevin Struhl
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 4.  Cytokine-induced nuclear translocation of signaling proteins and their analysis using the inducible translocation trap system.

Authors:  Shella Saint Fleur; Hodaka Fujii
Journal:  Cytokine       Date:  2008-01-18       Impact factor: 3.861

Review 5.  Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.

Authors:  E C LaCasse; Y A Lefebvre
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

6.  Identification of functional domains and evolution of Tc1-like transposable elements.

Authors:  Z Ivics; Z Izsvak; A Minter; P B Hackett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.

Authors:  J L Kolman; N Taylor; L Gradoville; J Countryman; G Miller
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.

Authors:  C Bogedain; H Wolf; S Modrow; G Stuber; W Jilg
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Splinkerettes--improved vectorettes for greater efficiency in PCR walking.

Authors:  R S Devon; D J Porteous; A J Brookes
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

10.  Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.

Authors:  E Pfitzner; P Becker; A Rolke; R Schüle
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.